Blog

There is a tremendous amount of noise surrounding GLP-1 medications right now. Depending on who is speaking, they are either the miracle answer to America’s obesity crisis or a dangerous shortcut for people who supposedly do not want to “do the work.” Both arguments are overly simplistic, and frankly, both are lazy. GLP-1 receptor agonists…

For nearly a century, we have called it polycystic ovary syndrome, or PCOS. That name is now changing. In May 2026, an international consensus group formally renamed PCOS Polyendocrine Metabolic Ovarian Syndrome, or PMOS. The change was published in The Lancet and reflects something clinicians and patients have recognized for years. This condition was never…

GLP-1 medications can improve weight loss and metabolic health, but emerging research suggests they may also influence dopamine, motivation, and reward pathways. Explore the science, patient experiences, and why vitality involves more than the number on a scale.